Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company

Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...

CRISPR Detectives: Startups seek to expand access to diagnostics with inexpensive CRISPR-based tests

CRISPR-Cas9 is best known for its powerful ability to make double-stranded breaks in DNA, allowing scientists to delete and edit genes with relative ease....

Brigham and Women’s Hospital Opens Preventive Genomics Clinic

Brigham and Women’s Hospital has launched the Preventive Genomics Clinic, a facility designed to provide comprehensive DNA sequencing, interpretation and reporting of disease-associated genes. The...

Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina

From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.
Source: efks/Getty Images

Top 15 Molecular Diagnostics M&A Deals of 2016

Molecular diagnostics accounts for only a tenth of the in vitro diagnostics (IVD) market—but most of its hopes for future revenue growth.
Clinician Offering Drugs Based On DNA Profiling

FDA Sends Warning Letter to Inova Over Pharmacogenomics Test

The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
pancreatic cancer cells

Researchers Identify Familial Pancreatic Cancer Gene

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

Genomind Launching Enhanced Mental Health Biomarker Test

Genomind said today it will launch an enhanced version of its mental health genetic test that will feature a new, more focused report and...

FoundationOne CDx Approved as Companion Diagnostic to Lynparza in Ovarian Cancer

The FDA has approved an expanded indication for Foundation Medicine’s FoundationOne®CDx, authorizing the test as a companion diagnostic for the AstraZeneca/Merck & Co. co-developed...
NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]

Polygenic Risk Scores Predict Heart Disease Across Diverse Populations

A new study confirms that the whole-genome approach for predicting heart disease in people who have never had a heart attack works and can...
Scroll Up